Bone marrow transplantation (BMT) recipients, particularly those with chronic graft-versus-host disease (GVHD), suffer from respiratory tract problems, including bronchiolitis obliterans (BO) and recurrent lower respiratory tract infections. Minute cilia beat continuously on the surface of respiratory mucosa, and this beating maintains the sterility of the lower respiratory tract. Dysfunction of respiratory cilia could lead to development of recurrent respiratory tract infections, which are also features of BMT recipients, although ciliary function has not been systematically studied among these subjects. We have, therefore, investigated the ciliary beat frequency (CBF) of 36 Chinese patients who had undergone allogeneic BMT. The CBF was significantly lower in the BMT group compared to controls (P Ͻ 0.001). The reduction in CBF was more severe in patients with cGVHD and BO compared with their counterparts (P = 0.048 and P = 0.077, respectively). There was a correlation between CBF with forced expiratory flow rate FEF (P = 0.024) and forced expiratory volume FEV (P = 0.044). We conclude that abnormal ciliary clearance is a common feature after allogeneic BMT, particularly among patients with BO and cGVHD. Further studies are indicated to evaluate this important phenomenon, which could be an important cause of the susceptibility for BMT recipients to respiratory infections. Bone Marrow Transplantation (2001) 27, 1147-1151. Keywords: bone marrow transplantation; ciliary function; bronchiolitis obliterans; graft-versus-host disease Survivors of bone marrow transplantation (BMT) often suffer from respiratory complications. These include conditioning toxicity, infective complications and bronchiliotis obliterans (BO).
in the absence of proven infection. The exact mechanism for the cause of such abnormalities after BMT is unknown, but there is a documented association with chronic graftversus-host disease (cGVHD), total body irradiation, and prior chemotherapy exposure. 2, 3 Cilia are minute hair-like structures present on the surface of respiratory mucosa. Each of these cilia beat continuously at 10-18 Hz, and this beating creates a constant flow of periciliary fluid, which is responsible for maintaining the sterility of the lower respiratory tract. Ciliary structure and function are highly conserved among all species and at different levels of the respiratory tract. 4 Dysfunction of respiratory cilia leads to development of recurrent upper and lower respiratory tract infections, bronchiectasis and small airway obstruction. This is exemplified by Kartagener's syndrome (sinusitis, bronchiectasis and dextrocardia) which is the most obvious clinical expression of a spectrum of diseases caused by abnormal ciliary function. 5 Defects in ciliary clearance are associated with small airway obstructive diseases and recurrent chest infections. 6 The role of ciliary dysfunction in post-BMT bronchiolitis obliterans (BO) is unknown and there has only been one report of nasal ciliary assessment in post-BMT patients with sinusitis. In this study, a high incidence of ultrastructural abnormalities was found, although data on ciliary beat frequency (CBF) were not presented. 7 We have, therefore, performed a cross-sectional evaluation of the functional characteristics of respiratory cilia, namely CBF, in a cohort of post-BMT recipients, with and without BO. We have also studied the correlation of CBF with important clinical parameters among this cohort.
Materials and methods
All allogeneic marrow recipients attending regular followup beyond 6 months after BMT were eligible for inclusion in the study. Among 168 patients seen over a 2 month period, 36 were recruited with written informed consent. The demographic and clinical characteristics of the cases are outlined in Table 1 . All the clinical charts were reviewed for each patient. Lung function tests were performed according to standard protocols, and results for FEV 1 , FEF and FVC were expressed as percent of predicted values. 8 All patients had documented normal lung function tests prior to BMT as part of standard work-up procedures. Post-BMT BO and GVHD were diagnosed according to standard criteria. 6,9 CBF was measured, using a photometric UPN = unique progression number; Cond = conditioning regimen; Dx = diagnosis; FU = follow-up time in months; CBF = ciliary beat frequency in Hertz; FEV 1 = forced expiratory volume in 1 s (% predicted); FEF = forced expiratory flow (% predicted); FVC = forced vital capacity; BO = bronchiolitis obliterans; cGVHD = chronic graft-versus-host disease; M = male; F = female; AML = acute myeloid leukemia; CML = chronic myeloid leukemia; ALL = acute lymphoblastic leukemia; HL = Hodgkin's lymphoma; Bu = busulphan; Cy = cyclophosphamide; TBI = total body irradiation; Y = yes; N = no.
technique as described previously. 10 Briefly, nasal epithelium was obtained without anaesthetic by a cytology brush from the inferior turbinate of patients, then re-suspended in 1.5 ml of medium 199 (Flow Laboratory, New York, NY, USA). The ciliated epithelium was examined using a Leica DM LB phase contrast microscope (with long working distance lenses) which had a warm stage maintained at 37°C (Leica, Wetzlar, Germany). The beating cilia, examined at 400×, were positioned to interrupt a light source and this frequency of interruption was conveyed to a MPV-COMBI photo-multiplier (Leica) and a custom-made digital converter which translated this into ciliary beat frequency (Hz) as described previously. 10 Light microscopy examination was also performed to determine whether or not there were any ciliary beating abnormalities such as dyskinesia or immotility. The ciliary assessment results of 54 randomly recruited healthy volunteers who had similar age and gender distribution were used as controls.
Results

Patient and control characteristics
The median age of study patients and control subjects was 34.6 ± 8.5 (range 17-56) and 34.7 ± 11.0 (range 11-60), respectively ( Table 1) . The male to female ratio was 1:1 in the study group and 1.4:1 in the control group. Gender and age distributions of the two groups were statistically comparable (P = 0.99 and P = 0.51, respectively). The underlying diagnoses for allogeneic BMT were acute myeloid leukemia (AML, n = 10), acute lymphoblastic leukemia (ALL, n = 4), chronic myeloid leukemia (CML, n = 20), severe aplastic anemia (n = 1) and Hodgkin's lymphoma (n = 1). Various conditioning regimens were used, including those with TBI (n = 16) and without TBI (n = 20). Clinically, BO was diagnosed in 18 BMT patients (50%) based on their lung function characteristics: manifested small airway obstruction in the absence of other causes such as asthma and COPD. 11 Five cases were classified as severe (FEV 1 Ͻ50% predicted), two cases as moderate (FEV 1 51-65% predicted) and 11 cases as mild (FEV 1 66-80% predicted). 9, 11 Treatment included inhalational steroids and beta-agonist, as well as oral azathioprine and prednisolone. Most of these patients suffered from cGVHD affecting other parts of the body including the skin, oral mucosa and liver. However, depending on the pattern of organ involvement, not all patients suffering from cGVHD had features of BO. Likewise, some BO patients displayed no features of cGVHD directed against other organs. None of the control subjects were known to suffer from any systemic illness or were on any regular medications.
Ciliary assessment and correlation analysis
The mean CBF in the study cases was 11.6 ± 1.84 Hz (range 7.0-14.6), compared with 13.5 ± 1.45 Hz (range 9.6-17.0) in the control group (P Ͻ 0.
001, Student's t-test).
A scatter plot of the CBF vs age showed an overlap in individual CBF between the BMT group of patients and the control group (Figure 1 ). Within the BMT group, the mean CBF for patients with cGVHD was significantly lower than that of patients without cGVHD (10.8 ± 2.3 Hz vs 12.1 ± 1.4 Hz, P = 0.048). There was a trend towards lower mean CBF for patients with BO compared to those without (10.8 ± 2.0 Hz vs 12.2 ± 1.4 Hz, P = 0.077). However, even the mean CBF among patients without BO was significantly lower than that of the control subjects (12.2 ± 1.4 Hz vs 13.5 ± 1.4 Hz, P = 0.001). Also within the group of BMT recipients, significant correlation was found between impaired CBF and low FEV 1 (r = 0.26, P = 0.044); low FEF Bone Marrow Transplantation ratio (r = 0.38, P = 0.009) (Spearman's non-parametric test, one tailed), which are indicators of disease severity for BO. There was no correlation between CBF and age (r = 0.063, P = 0.23). There was no significant difference in CBF among men and women (P = 0.93) or patients with or without history of TBI (P = 0.958) (Student's t-test).
Discussion
Bronchiolitis obliterans is the most significant pulmonary cause of morbidity and mortality among BMT survivors, and accounts for over 30% of deaths. 12, 13 The incidence after BMT is around 20%.
14 Immune-mediated destruction of small airways causing obstructive lung defect is the hallmark of the disease and the diagnosis of BO is usually made on the appropriate clinical setting, supported by lung function test results, with or without computed tomography (CT) and histological changes. Serial lung function test showing obstructive defect is the most sensitive method for detecting early BO and for monitoring disease progress. 15 Patients either run a static course with permanent residual pulmonary defect, or a relentless deteriorating course lead to respiratory failure. 14 The treatment included steroids, beta-agonists and immunosuppression, but end-stage patients can only be salvaged by lung transplantation. 16 As an allo-immune disease, BO does not affect the native lung after single lung transplantation, and rarely occurs after autologous BMT. 17 While T cells and macrophages have been shown to be involved in the pathogenesis of post-BMT BO in a murine model, there is evidence that humoral-mediated immunity may also be involved. 18 Probably due to a lack of equipment and research expertise, despite its high potential relevance in the increased susceptibility of respiratory infections, respiratory ciliary function had rarely been studied in BMT recipients. In the only published study on 15 patients (including four autologous BMT cases), CBF was reported to be within the normal range, despite a high incidence of abnormalities on electron microscopy. 7 However, there was no control group in this study for comparison of CBF. In addition, the authors elected to regard ciliary beat frequency as normal when it was у8 Hz when the usually quoted normal range is 10-16 Hz. 19 The authors of this paper also reported ciliary abnormalities including squamous metaplasia although this is generally not regarded as a 'ciliary' abnormality in the conventional assessment of respiratory mucosa. It is well known that apparently even healthy subjects could have high incidences of ciliary abnormalities. These include complete absence or deficiency of outer or inner dynein arms, nexin links, radial spokes, central sheath, inner microtubules, and even the entire axoneme. [20] [21] [22] The significance of isolated ciliary ultrastructural abnormalities without functional deficit is, however, debatable. 23 Our study showed, for the first time, that allogeneic BMT was associated with ciliary dysfunction, especially for patients suffering from GVHD and BO. Our positive results might have been due to the inclusion of more cases with BO and GVHD. The difference was also apparent when compared with a matched control group, since the normal range of CBF extended over a wide range, and a significant overlap occurs between normal and abnormal values. 21, 24 On the other hand, CBF abnormalities in BO patients after lung transplantation have been extensively studied. Transient reversible ciliary dysfunction occurs in all patients who have had lung transplantation. 25 For patients with BO, however, the CBF remained depressed. The defect is confined to the transplanted side and represents a form of chronic rejection. 26 Reduced mucociliary clearance will lead to stagnation of respiratory mucus, which amasses cell debris along with inhaled bacteria in the upper and lower respiratory tract. This could, in turn, create a vicious cycle of infection, inflammation, airway destruction, and possibly secondary ciliary dysfunction. 27, 28 In BMT patients, BO occurs due to GVHD against the native lung. The incidence, clinical features and pathology of BO in the two groups of transplantation patients are similar and may represent the same disease. 29 It is, therefore, possible that reduction in CBF is a primary abnormal finding in BMT patients with BO. Chronic infection by common respiratory pathogens such as Haemophilus influenzae and Pseudomonas aeruginosa, could also lead to impairment of ciliary beat. 19, 30 Alternatively, it is also possible that the treatment process for BMT recipients could be the cause of depressed ciliary function in these patients. Clinically, it might be useful to screen post BMT patients for CBF abnormalities for early prediction of BO before lung function abnormalities. Patients with more severe CBF depression may also be predisposed to a more sinister clinical course of BO. Drugs that stimulate mucociliary clearance and reduce local inflammation may be tried early before inflammation and fibrosis become well established. 31, 32 This hypothesis will need to be prospectively tested by serial monitoring of a larger cohort of patients who are patients at risk for the development of BO after BMT.
